Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation
- PMID: 38890429
- PMCID: PMC11281901
- DOI: 10.1038/s41388-024-03080-7
Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation
Erratum in
-
Correction: Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation.Oncogene. 2025 Jul;44(24):2004-2007. doi: 10.1038/s41388-025-03439-4. Oncogene. 2025. PMID: 40456867 Free PMC article. No abstract available.
Abstract
The role of tumor-resident microbiota in modulating tumor immunity remains unclear. Here, we discovered an abundance of intra-tumoral bacteria, such us E.coli, residing and resulting in Colorectal cancer liver metastasis (CRLM). E.coli enhanced lactate production, which mediated M2 macrophage polarization by suppressing nuclear factor-κB -gene binding (NF-κB) signaling through retinoic acid-inducible gene 1 (RIG-I) lactylation. Lactylation of RIG-I suppressed recruitment of NF-κB to the Nlrp3 promoter in macrophages, thereby reducing its transcription. This loss of Nlrp3 affected the immunosuppressive activities of regulatory T cells (Tregs) and the antitumor activities of and CD8+ T cells. Small-molecule compound screening identified a RIG-I lactylation inhibitor that suppressed M2 polarization and sensitized CRLM to 5-fluorouracil (5-FU). Our findings suggest that tumor-resident microbiota may be a potential target for preventing and treating CRLM.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.J Immunother Cancer. 2019 Aug 8;7(1):215. doi: 10.1186/s40425-019-0701-2. J Immunother Cancer. 2019. PMID: 31395078 Free PMC article.
-
CD38 modulates cytokine secretion by NK cells through the Sirt1/NF-κB pathway, suppressing immune surveillance in colorectal cancer.Sci Rep. 2024 Nov 20;14(1):28702. doi: 10.1038/s41598-024-79008-8. Sci Rep. 2024. PMID: 39562615 Free PMC article.
-
Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.Immunol Invest. 2023 Apr;52(3):364-397. doi: 10.1080/08820139.2023.2168554. Epub 2023 Feb 6. Immunol Invest. 2023. PMID: 36745138 Review.
-
miR-122/NEGR1 axis contributes colorectal cancer liver metastasis by PI3K/AKT pathway and macrophage modulation.J Transl Med. 2024 Nov 25;22(1):1060. doi: 10.1186/s12967-024-05901-5. J Transl Med. 2024. PMID: 39587606 Free PMC article.
-
The role of Fusobacterium nucleatum in macrophage M2 polarization and NF-κB pathway activation in colorectal cancer.Front Immunol. 2025 Apr 3;16:1549564. doi: 10.3389/fimmu.2025.1549564. eCollection 2025. Front Immunol. 2025. PMID: 40248690 Free PMC article.
Cited by
-
The lactylation-macrophage interplay: implications for gastrointestinal disease therapeutics.Front Immunol. 2025 Jul 9;16:1608115. doi: 10.3389/fimmu.2025.1608115. eCollection 2025. Front Immunol. 2025. PMID: 40703527 Free PMC article. Review.
-
Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies.Exp Hematol Oncol. 2025 Mar 8;14(1):32. doi: 10.1186/s40164-025-00622-x. Exp Hematol Oncol. 2025. PMID: 40057816 Free PMC article. Review.
-
Lactylation in health and disease: physiological or pathological?Theranostics. 2025 Jan 2;15(5):1787-1821. doi: 10.7150/thno.105353. eCollection 2025. Theranostics. 2025. PMID: 39897556 Free PMC article. Review.
-
The role of macrophages in liver metastasis: mechanisms and therapeutic prospects.Front Immunol. 2025 Feb 17;16:1542197. doi: 10.3389/fimmu.2025.1542197. eCollection 2025. Front Immunol. 2025. PMID: 40034694 Free PMC article. Review.
-
Exploring the role of gut microbiota in colorectal liver metastasis through the gut-liver axis.Front Cell Dev Biol. 2025 Mar 13;13:1563184. doi: 10.3389/fcell.2025.1563184. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40181829 Free PMC article. Review.
References
-
- Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713–32. - PubMed
-
- Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467–80. - PubMed
-
- Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179:829–845 e820. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials